Changing the future of Oncology.

News 

Sutro Biopharma Announces Proposed Public Offering

South San Francisco, Calif., May 11, 2020 -- Sutro Biopharma, Inc. (Nasdaq: STRO), a clinical stage drug discovery, development and manufacturing company focused on deploying its proprietary integrated cell-free protein synthesis platform, XpressCF®, to create a broad...

read more